NCT07228078RecruitingPhase 2
Open-Label Extension Protocol to SNK01-AD01 Study
An Open-Label Extension (OLE) Study to Evaluate the Long-Term Safety, Tolerability and Exploratory Efficacy of SNK01 in Participants With Alzheimer's Disease (Study SNK01-AD02)
Source: ClinicalTrials.gov · Last updated 13 Nov 2025
Brief summary (registry, in English)
Open-Label Extension Protocol to SNK01-AD01 Study
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- First submitted
- 12 Nov 2025
- Start date
- 30 Jun 2025
- Primary completion date
- Apr 2028
- Lead sponsor
- NKGen Biotech, Inc.
- Diseases
- Alzheimer disease
- NCT number
- NCT07228078
What you commit to
- Study type: Interventional · Phase 2
- Planned participants: 30
- From 30 Jun 2025 to the primary completion date, Apr 2028
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Participants who fulfill any of the following criteria will not be recruited into the study:
- Any participant whose safety the investigator considers to be at risk from this trial's intervention.
Who the study is looking for
- Participants will be considered eligible for participation in the study if all the following criteria are satisfied:
- The participant or their legally authorized representative must be willing and able to give their informed consent in writing and comply with the requirements of this study protocol. Informed consent for participants or their legally authorized representative and caregivers will be obtained before any trial-related activity. (Trial-related activities are any procedure that would not be performed during normal treatment of the subject).
- Participants must have a reliable study partner/caregiver (per investigator judgement for instance a family member, partner etc., guardian (must be always the same person)) who is in close contact with the patient, available on call and who is able to contribute to the assessment of the ratings of the functional endpoints at specific study visits. This person will be able to communicate in the language in which the participant is being assessed and should also serve as a backup contact for the study site.
- Participants previously completed participation in study SNK01-AD01.
Age in the registry: 40 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Behavioral Research Specialists, LLC Coordinator of this site? Confirm its status | Glendale | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.